• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Market Market
    Market News
    Market Stocks
    • Market Market
    • Market News
    • Market Stocks
    life science investing

    Blood Pressure Drugs May Slow Effects of Alzheimer’s

    Investing News Network
    Jul. 31, 2013 09:36AM PST
    Market News

    New research shows that common drugs used to lower blood pressure can slow the rate of cognitive decline associated with people with Alzheimer’s disease, reported Pharmaceutical-Technology.com.

    New research shows that common drugs used to lower blood pressure can slow the rate of cognitive decline associated with people with Alzheimer’s disease, reported Pharmaceutical-Technology.com.

    As quoted in the market news:

    Researchers compiled rates of cognitive decline in 361 patients who had either Alzheimer’s disease, vascular dementia or a mix of both.

    Of the 361 patients, 85 were taking ACE inhibitors, which is a blood pressure lowering medication.

    Click here for the full news story by Pharmaceutical-Technology.com.

    life science investing
    The Conversation (0)

    Go Deeper

    AI Powered
    Man holds hand to head as fragments break off representing Alzheimer's disease.

    Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

    Anavex Life Sciences Announces Continued Long-Term Benefit from Oral Blarcamesine Compared to Decline Observed in the Alzheimer's Disease Neuroimaging Initiative Control Group

    Latest News

    Apple reports fourth quarter results

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    Defence Therapeutics Class A

    DTC:CC

    Cloud DX

    CDX:CA

    BioHarvest Sciences

    BHSC:CNX

    Billy Goat Brands

    GOAT:CC

    Contakt World

    HELP:CNX
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES